Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis.

Hanazono, Akira; Sanpei, Yui; Shimada, Hinako; Yasuda, Keita; Takahashi, Yoshiko; Funasaka, Homare; Sagehashi, Ryuichiro; Hiroshima, Yuko; Nanjo, Hiroshi; Sugawara, Masashiro

Hanazono, Akira; Sanpei, Yui; Shimada, Hinako; Yasuda, Keita; Takahashi, Yoshiko; Funasaka, Homare; Sagehashi, Ryuichiro; Hiroshima, Yuko; Nanjo, Hiroshi; Sugawara, Masashiro.

Afiliación

Hanazono A; Akita University Graduate School of Medicine, Department of Neurology, Japan.
Sanpei Y; Akita University Graduate School of Medicine, Department of Neurology, Japan.
Shimada H; Akita University Graduate School of Medicine, Department of Neurology, Japan.
Yasuda K; Akita University Graduate School of Medicine, Department of Neurology, Japan.
Takahashi Y; Akita University Graduate School of Medicine, Department of Neurology, Japan.
Funasaka H; Akita University Graduate School of Medicine, Department of Neurology, Japan.
Sagehashi R; Akita University Graduate School of Medicine, Department of Urology, Japan.
Hiroshima Y; Akita University Hospital, Division of Clinical Pathology, Japan.
Nanjo H; Akita University Hospital, Division of Clinical Pathology, Japan.
Sugawara M; Akita University Graduate School of Medicine, Department of Neurology, Japan.

eNeurologicalSci ; 29: 100428, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36193452

Palabras clave

Dimethyl fumarate; IgG4-related disease; Interferon ß1b; Rituximab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ENeurologicalSci Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google